| P2093 | author name string | Yijuan Du | |
| | Steven M Graves | |
| P2860 | cites work | Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. | Q21135493 |
| | Synaptic organisation of the basal ganglia | Q24544917 |
| | Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry | Q24630976 |
| | The thalamostriatal system in normal and diseased states | Q26996624 |
| | Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice | Q27308060 |
| | A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice | Q27324171 |
| | Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice | Q28513036 |
| | Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons | Q28590748 |
| | Ageing and Parkinson's disease: substantia nigra regional selectivity | Q29615835 |
| | D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons | Q29619181 |
| | Balanced activity in basal ganglia projection pathways is critical for contraversive movements | Q30434712 |
| | Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 |
| | Concurrent activation of striatal direct and indirect pathways during action initiation. | Q30579307 |
| | Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia | Q30650489 |
| | Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling. | Q30762059 |
| | Evidence of a breakdown of corticostriatal connections in Parkinson's disease. | Q33214147 |
| | Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein | Q33577056 |
| | Different corticostriatal integration in spiny projection neurons from direct and indirect pathways | Q33944484 |
| | Clinical progression in Parkinson disease and the neurobiology of axons. | Q34052764 |
| | A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions | Q34094065 |
| | Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss | Q34116613 |
| | MitoPark mice mirror the slow progression of key symptoms and L-DOPA response in Parkinson's disease | Q34133023 |
| | Exercise modifies α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor expression in striatopallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse | Q34362073 |
| | Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease | Q34390400 |
| | Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. | Q34521936 |
| | Place learning strategy of substantia nigra pars compacta-lesioned rats | Q34597317 |
| | Cognitive dysfunction precedes the onset of motor symptoms in the MitoPark mouse model of Parkinson's disease | Q34970932 |
| | Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons | Q35611727 |
| | Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit. | Q35782721 |
| | (G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD. | Q36223954 |
| | LRRK2 BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function | Q36581417 |
| | M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia | Q36892615 |
| | Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses | Q37048087 |
| | Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation | Q37080018 |
| | Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys | Q37186952 |
| | Control of basal ganglia output by direct and indirect pathway projection neurons. | Q37325384 |
| | L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia | Q37344222 |
| | Striatal Neurons Expressing D1 and D2 Receptors are Morphologically Distinct and Differently Affected by Dopamine Denervation in Mice | Q37609566 |
| | Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations | Q38086676 |
| | Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice. | Q52147573 |
| | Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3-/- Mice, a Genetic Model of Parkinson's Disease. | Q53446566 |
| | Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 | Q57058859 |
| | Dual Dopaminergic Regulation of Corticostriatal Plasticity by Cholinergic Interneurons and Indirect Pathway Medium Spiny Neurons | Q58749186 |
| | Delayed Spine Pruning of Direct Pathway Spiny Projection Neurons in a Mouse Model of Parkinson's Disease | Q64251973 |
| | Changes in Dendritic Spine Density and Inhibitory Perisomatic Connectivity onto Medium Spiny Neurons in L-Dopa-Induced Dyskinesia | Q64780255 |
| | Implication of nigral dopaminergic lesion and repeated L-dopa exposure in neuropsychiatric symptoms of Parkinson's disease | Q64796987 |
| | Striatal cholinergic interneurons regulate cognitive and affective dysfunction in partially dopamine-depleted mice | Q64859946 |
| | Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein | Q64868288 |
| | Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease | Q68502274 |
| | Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age | Q69262673 |
| | Morphologic changes of dendritic spines of striatal neurons in the levodopa-induced dyskinesia model | Q87366704 |
| | PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity | Q39647087 |
| | Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease. | Q39735904 |
| | MPTP-induced deficits in striatal synaptic plasticity are prevented by glial cell line-derived neurotrophic factor expressed via an adeno-associated viral vector. | Q40095787 |
| | Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models | Q41584434 |
| | Parkinsonism Driven by Antipsychotics Originates from Dopaminergic Control of Striatal Cholinergic Interneurons | Q41831385 |
| | Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET. | Q41953550 |
| | Effects of SR141716A on Cognitive and Depression-Related Behavior in an Animal Model of Premotor Parkinson's Disease. | Q42408299 |
| | L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice. | Q42440010 |
| | Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia | Q42452008 |
| | Altered AMPA receptor expression with treadmill exercise in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury | Q42459653 |
| | Input- and cell-type-specific endocannabinoid-dependent LTD in the striatum. | Q42470816 |
| | Coordinated Regulation of Synaptic Plasticity at Striatopallidal and Striatonigral Neurons Orchestrates Motor Control | Q42484851 |
| | Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease | Q42498429 |
| | Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 |
| | Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition. | Q42852538 |
| | [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression | Q43820139 |
| | Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia | Q44383212 |
| | Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice | Q44493207 |
| | Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease | Q45346135 |
| | Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates. | Q46078772 |
| | Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease. | Q46346508 |
| | Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity | Q46378697 |
| | Cognitive impairment and dentate gyrus synaptic dysfunction in experimental parkinsonism | Q46491041 |
| | Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. | Q46896175 |
| | Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons. | Q46973834 |
| | Dynamic Changes in Striatal mGluR1 But Not mGluR5 during Pathological Progression of Parkinson's Disease in Human Alpha-Synuclein A53T Transgenic Rats: A Multi-PET Imaging Study | Q47580972 |
| | Plastic changes at corticostriatal synapses predict improved motor function in a partial lesion model of Parkinson's disease. | Q47962017 |
| | Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease. | Q48114419 |
| | Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. | Q48165522 |
| | Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area | Q48284775 |
| | (G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse | Q48294256 |
| | The presence of perforated synapses in the striatum after dopamine depletion, is this a sign of maladaptive brain plasticity? | Q48524164 |
| | Haloperidol Selectively Remodels Striatal Indirect Pathway Circuits | Q48541253 |
| | Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT. | Q48545197 |
| | Inducible ablation of dopamine D2 receptors in adult mice impairs locomotion, motor skill learning and leads to severe parkinsonism | Q48616861 |
| | Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice. | Q48847188 |
| | Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease | Q49069694 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| | synaptic plasticity | Q1551556 |
| | striatum | Q1319792 |
| | Parkinson’s Disease | Q39074077 |
| P304 | page(s) | 17 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Frontiers in neural circuits | Q27721914 |
| P1476 | title | Spiny Projection Neuron Dynamics in Toxin and Transgenic Models of Parkinson's Disease | |
| P478 | volume | 13 | |